Nicholas F. Reuter

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.

Richard M. Goldberg, Charles L. Loprinzi, J A Mailliard et al. · Journal of Clinical Oncology · 1995 · 187 citations

Medicine, Oncology, Pharmacology +15

Brief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study

Thanyanan Reungwetwattana, Julian R. Molina, Sumithra J. Mandrekar et al. · Journal of Thoracic Oncology · 2012 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Sumithra J. Mandrekar, Yingwei Qi, Shauna L. Hillman et al. · Journal of Thoracic Oncology · 2010 · 38 citations · Full text

Medicine, Oncology, Metastasis +9

A front-line window of opportunity phase II study of sorafenib in patients with advanced non-small cell lung cancer: A North Central Cancer Treatment Group study

Alex A. Adjei, Julian R. Molina, Shauna L. Hillman et al. · Journal of Clinical Oncology · 2007 · 37 citations

Medicine, Oncology, Pharmacology +14

Transdermal fentanyl in the management of cancer pain in ambulatory patients: An open-label pilot study

Julie E. Hammack, James A. Mailliard, Charles L. Loprinzi et al. · Journal of Pain and Symptom Management · 1996 · 25 citations · Full text

Nursing, Oncology, Pharmacotherapy +17